Mammalian Target of Rapamycin and Hepatocellular Carcinoma: The Question's Always There, Until We Choose To Answer It

Liver Transpl. 2022 Jun;28(6):931-932. doi: 10.1002/lt.26454. Epub 2022 Apr 2.

Authors

Christopher J Danford¹, Richard Gilroy

Affiliation

¹ 98078 Transplantation Services Intermountain Medical Center Murray UT.

PMID: 35289072
DOI: 10.1002/lt.26454

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Hepatocellular* / drug therapy
Carcinoma, Hepatocellular* / surgery
Humans
Liver Neoplasms* / drug therapy
Liver Neoplasms* / surgery
Liver Transplantation*
Sirolimus / therapeutic use
TOR Serine-Threonine Kinases

Substances

TOR Serine-Threonine Kinases
Sirolimus